New PET scan tracer could spot keloids without a biopsy

NCT ID NCT07660406

Recruiting now Diagnosis Sponsor: Peking Union Medical College Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a special PET-CT scan using a radioactive tracer called 68Ga-RGD can help doctors diagnose keloids and see how well treatment is working. Keloids are raised scars that grow beyond the original wound, and current diagnosis relies on physical exams. The trial will enroll 30 adults with keloids to see if the scan matches clinical symptoms and lab tests. It is an early-phase study, so the results are not yet proven.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 68Ga-RGD (a radioactive tracer injected intravenously for PET-CT imaging)
What this could lead to: If successful, this imaging method could provide a new way to diagnose keloids and monitor treatment effectiveness without invasive biopsies.
What could go wrong: This is an early-phase study with only 30 participants, so results may not apply to everyone. The tracer is experimental and its accuracy for keloid diagnosis is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KELOID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

keloid

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KELOID

Contacts and locations

Locations

Peking Union Medical College Hospital
RECRUITING

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.